Table 2.
Baseline characteristics.
| Characteristic | Values (N=40) | ||
| Age (years), mean (SD) | 80.5 (10.4) | ||
| Ejection fraction (%), mean (SD) | 41.6 (17.9) | ||
| Systolic blood pressure (mmHg), mean (SD) | 127.5 (19.4) | ||
| Diastolic blood pressure (mmHg), mean (SD) | 67.7 (9.6) | ||
| Sex, n (%) |
|
||
|
|
Male | 20 (50) | |
|
|
Female | 20 (50) | |
| Race, n (%) |
|
||
|
|
Black | 11 (28) | |
|
|
Hispanic | 2 (5) | |
|
|
Asian | 1 (3) | |
|
|
White | 26 (65) | |
| HFa type, n (%) |
|
||
|
|
HF with reduced ejection fraction | 21 (53) | |
|
|
HF with preserved ejection fraction | 16 (40) | |
|
|
Unknown | 3 (8) | |
| Coronary artery disease, n (%) | 17 (43) | ||
| Stroke, n (%) | 4 (10) | ||
| Hypertension, n (%) | 38 (95) | ||
| Diabetes, n (%) | 10 (25) | ||
| Chronic kidney disease, n (%) | 15 (38) | ||
| Serum creatinine, mean (SD) | 1.64 (1) | ||
| Chronic obstructive pulmonary disease, n (%) | 5 (13) | ||
| New York Heart Association Class, n (%) |
|
||
|
|
I | 0 (0) | |
|
|
II-III | 37 (93) | |
|
|
IV | 3 (8) | |
| ACEIb, ARBc, or ARNId, n (%) | 11 (28) | ||
| Beta blocker, n (%) | 28 (70) | ||
| Loop diuretic, n (%) | 36 (90) | ||
| Aldosterone inhibitor, n (%) | 7 (18) | ||
| Intravenous inotrope, n (%) | 3 (8) | ||
aHF: heart failure.
bACEI: angiotensin-converting enzyme inhibitor.
cARB: angiotensin receptor blocker.
dARNI: angiotensin receptor-neprilysin inhibitor.